Enhancing Treatment of Hepatitis C in Opioid Substitution Settings II (ETHOS II): A partnership project to enhance hepatitis C care in drug and alcohol clinics

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This Partnership Project will evaluate novel strategies to enhance care for hepatitis C infection in drug and alcohol clinics. Based on a foundation of strong, existing partnerships, this project has considerable potential to facilitate the translation of research outcomes into policy and practice and facilitate the scale-up of hepatitis C care in drug and alcohol clinics in NSW and nationally.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2020

Funding Scheme: Partnerships

Funding Amount: $1,265,716.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

health policy | hepatitis C infection | injecting drug use | liver disease | treatment